Comparing the Overall Result and Interaction in Aggregate Data Meta-Analysis and Individual Patient Data Meta-Analysis

Medicine (United States)

Volumn 95, Issue 14, 2016, Pages

  Huang, Yafang ^a   Tang, Jinling ^c   Tam, Wilson Wai San ^b   Mao, Chen ^c   Yuan, Jinqiu ^c   Di, Mengyang ^c   Yang, Zuyao ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATE DATA META ANALYSIS; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; DATA EXTRACTION; DISEASE SEVERITY; HUMAN; INDIVIDUAL PATIENT DATA META ANALYSIS; INTENTION TO TREAT ANALYSIS; META ANALYSIS (TOPIC); PATIENT CODING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STUDY DESIGN; COMPARATIVE STUDY;

META-ANALYSIS AS TOPIC;

EID: 84964687214     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003312     Document Type: Article

References (28)

1. DerSimonian R, Laird N. Meta-Analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
2. Higgins J, Thompson S, Spiegelhalter D. A re-evaluation of random-effects meta-Analysis. J Royal Statistical Soc Series A. 2009;172:137-159.
3. Harvey I, Peters T, Toth B. Meta-Analysis. Lancet. 1993;341:964-965.
4. Smith CT, Oyee J, Marcucci M, et al. Individual participant data meta-Analyses compared with meta-Analyses based on aggregate data. Trials. 2011;12:A57.
5. Sutton AJ, Kendrick D, Coupland CAC. Meta-Analysis of individual-And aggregate-level data. Stat Med. 2008;27:651-669.
6. Stewart LA, Tierney JF. To IPD or not to IPD? Eval Health Prof. 2002;25:76-97.
7. Teramukai S, Matsuyama Y, Mizuno S, et al. Individual patient-level and study-level meta-Analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol. 2004;34:717-721.
8. Koopman L, van der Heijden GJ, Glasziou PP, et al. A systematic review of analytical methods used to study subgroups in (individual patient data) meta-Analyses. J Clin Epidemiol. 2007;60:1002-1009.
9. Riley RD, Lambert PC, Abo-Zaid G. Meta-Analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.
10. Rathi V, Dzara K, Gross CP, et al. Sharing of clinical trial data among trialists: a cross sectional survey. BMJ. 2012;345:e7570.
11. Lyman G, Kuderer N. The strengths and limitations of meta-Analyses based on aggregate data. BMC Med Res Methodol. 2005;5:14.
12. Kovalchik SA. Survey finds that most meta-Analysts do not attempt to collect individual patient data. J Clin Epidemiol. 2012;65: 1296-1299.
13. Duchateau L, Pignon JP, Bijnens L, et al. Individual patient-versus literature-based meta-Analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. Control Clin Trials. 2001;22:538-547.
14. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-Analytic results using literature vs individual patient data. JAMA. 1995;274:830-836.
15. Stewart LA, Parmar M.K.B. Meta-Analysis of the literature or of individual patient data: is there a difference? Lancet. 1993;341:418-422.
16. Clarke M, Godwin J. Systematic reviews using individual patient data: a map for the minefields? Ann Oncol. 1998;9:827-833.
17. Pignon JP, Arriagada R. Role of thoracic radiotherapy in limited-stage small-cell lung cancer: quantitative review based on the literature versus meta-Analysis based on individual data. J Clin Oncol. 1992;10:1819-1820.
18. Steinberg KK, Smith SJ, Stroup DF, et al. Comparison of effect estimates from a meta-Analysis of summary data from published studies and from a meta-Analysis using individual patient data for ovarian cancer studies. Am J Epidemiol. 1997;145:917-925.
19. Huang Y, Mao C, Yuan J, et al. Distribution and epidemiological characteristics of published individual patient data meta-Analyses. PLoS One. 2014;9:e100151.
20. Montori VM, Wilczynski NL, Morgan D, et al. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. BMJ. 2005;330:68.
21. LeLorier J, Grégoire G, Benhaddad A, et al. Discrepancies between meta-Analyses and subsequent large randomized, controlled trials. N Engl J Med. 1997;337:536-542.
22. Schardt C, Adams MB, Owens T, et al. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:16.
23. Matthews JN, Altman DG. Interaction 3: how to examine heterogeneity. BMJ. 1996;313:862.
24. Villar J, Carroli G, Belizán JM. Predictive ability of meta-Analyses of randomised controlled trials. Lancet. 1995;345:772-776.
25. Song F, Xiong T, Parekh-Bhurke S, et al. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ. 2011;343:d4909.
26. Gregoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-Analysis: is there a Tower of Babel bias? J Clin Epidemiol. 1995;48:159-163.
27. Ahmed I, Sutton AJ, Riley RD. Assessment of publication bias, selection bias, and unavailable data in meta-Analyses using individual participant data: a database survey. BMJ. 2012;344:d7762.
28. Garrow JS. What to do about CAM: how much of orthodox medicine is evidence based? BMJ. 2007;335:951.